About: Severe flu management: a point of view

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Severe flu management: a point of view Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Severe flu management: a point of view
Creator	Lee, Nelson Torres, Antoni Sligl, Wendy
Source	PMC
abstract	Annual flu seasons are typically characterized by changes in types and subtypes of influenza, with variations in terms of severity. Despite remarkable improvements in the prevention and management of patients with suspected or laboratory-confirmed diagnosis of influenza, annual seasonal influenza continues to be associated with a high morbidity and mortality. Admission to the intensive care unit is required for patients with severe forms of seasonal influenza infection, with primary pneumonia being present in most of the cases. This review summarizes the most recent knowledge on the diagnosis and treatment strategies in critically ill patients with influenza, focused on diagnostic testing methods, antiviral therapy, use of corticosteroids, antibacterial and antifungal therapy, and supportive measures. The review focuses on diagnostic testing methods, antiviral therapy, use of corticosteroids, antibacterial and antifungal therapy, supportive measures and relevant existing evidence, in order to provide the non-expert clinician a useful overview. An enhanced understanding of current diagnostic and treatment aspects of influenza infection can contribute to improve outcomes and reduce mortality among ICU patients with influenza.
has issue date	2020-01-07(xsd:dateTime)
bibo:doi	10.1007/s00134-019-05868-8
bibo:pmid	31912206
has license	no-cc
sha1sum (hex)	ba691c6672d2c31ebfde2f605d4283681b324e5c
schema:url	https://doi.org/10.1007/s00134-019-05868-8
resource representing a document's title	Severe flu management: a point of view
has PubMed Central identifier	PMC7095473
has PubMed identifier	31912206
schema:publication	Intensive Care Med
resource representing a document's body	covid:ba691c6672d2c31ebfde2f605d4283681b324e5c#body_text
is schema:about of	named entity 'supportive' named entity 'flu' named entity 'improvements' named entity 'survival' named entity 'Neuraminidase inhibitors' named entity 'therapy' named entity 'order' named entity 'pdf' named entity 'mortality' named entity 'pneumonia' named entity 'MOST OF' named entity 'PRIMARY' named entity 'ANTIVIRAL AGENTS' named entity 'KNOWLEDGE' named entity 'DATA' named entity 'FOCUSED' named entity 'AFFECT' named entity 'ADMISSION' named entity 'LABORATORY' named entity 'REDUCE' named entity '20192' named entity 'MORTALITY' named entity 'SUPPORTIVE' named entity 'INFLUENZA INFECTION' named entity 'PRESENT' named entity 'morbidity' named entity 'attac' named entity 'measures' named entity 'mortality' named entity 'influenza' named entity 'patients' named entity '2019' named entity 'improve' named entity 'influenza' named entity 'flu' named entity 'Neuraminidase inhibitors' named entity 'antiviral therapy' named entity 'diagnostic testing' named entity 'influenza' named entity 'influenza' named entity 'supportive measures' named entity 'morbidity' named entity 'superinfection' named entity 'ICU' named entity 'CRP' named entity 'influenza' named entity 'hypoxemia' named entity 'corticosteroids' named entity 'PHE' named entity 'COPD' named entity 'oseltamivir' named entity 'virological' named entity 'antigen' named entity 'enteral' named entity 'observational studies' named entity 'inflammatory cytokines' named entity 'renal failure' named entity 'antimicrobial agents' named entity 'laboratory tests' named entity 'refractory' named entity 'observational study' named entity 'enteral' named entity 'Aspergillus' named entity 'refractory' named entity 'enteral' named entity 'NIV' named entity 'corticosteroids' named entity 'parainfluenza virus' named entity 'digital PCR' named entity 'multiorgan failure' named entity 'mortality rate' named entity 'antiviral' named entity 'invasive aspergillosis' named entity 'critically ill' named entity 'antifungal treatment' named entity 'ventilator-associated' named entity 'neuraminidase inhibitors' named entity 'influenza' named entity 'pregnancy'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software